Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-β signaling

doi:10.3748/wjg.v11.i19.2922

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 11, Issue 19

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (2685)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

336

HTML

1889

Figures (1-5)

266

Tables (1-1)

194

Sum=2685

May 21, 2005 (publication date) through Nov 20, 2024

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Basic Research

World J Gastroenterol. May 21, 2005; 11(19): 2922-2926
Published online May 21, 2005. doi: 10.3748/wjg.v11.i19.2922

Full Size Figure Download Figure

Figure 3 RT-PCR determination of Smad 7 and TGF-β₁ mRNA expressions. Lane 1: 100-bp marker, lane 2: control group, lanes 3-6: treatment with tetrandrine at 0.25, 0.5, 1.0, 2.0 mg/L, respectively.

Citation: Chen YW, Wu JX, Chen YW, Li DG, Lu HM. Tetrandrine inhibits activation of rat hepatic stellate cells in vitro via transforming growth factor-β signaling. World J Gastroenterol 2005; 11(19): 2922-2926
URL: https://www.wjgnet.com/1007-9327/full/v11/i19/2922.htm
DOI: https://dx.doi.org/10.3748/wjg.v11.i19.2922